COVID-19
- Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273. Verstegen, Niels et al. eLife vol. 11 e77969. 15 Jul. 2022, doi:10.7554/eLife.77969
- Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study. Wieske et al. The Lancet. Rheumatology vol. 4,5 (2022): e338-e350. doi:10.1016/S2665-9913(22)00034-0
- Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies. Boekel et al. The Lancet. Rheumatology vol. 3,11 (2021): e778-e788. doi:10.1016/S2665-9913(21)00222-8
- SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort. Van Kempen et al. JAMA neurology vol. 78,7 (2021): 880-882. doi:10.1001/jamaneurol.2021.1364
